UofT Magazine Highlights Prof. Scott Gray-Owen and the Emerging and Pandemic Infections Consortium
MoGen in the News
Photos by Nathan Cyprys
The University of Toronto Magazine recently highlighted MoGen faculty member and the C-CL3 director Dr. Scott Gray-Owen, specifically with the Emerging and Pandemic Infections Consortium (EPIC). The piece covers how the consortium emerged during the pandemic, research goals and priorities, what kinds of scientists and companies EPIC plan to partner with, and much more.
Researchers from the University of Toronto's Department of Molecular Genetics, led by Dr. Xi Huang and Dr. Weifan Dong, have developed a groundbreaking designer peptide therapy targeting glioblastoma (GBM). Their innovative approach disrupts a tumour-specific potassium channel complex, offering promising advancements in GBM treatment.
The team applied machine learning, a type of artificial intelligence that recognizes patterns in vast amounts of data, to gene expression data obtained from individual cells.